Learning Objectives:

  1. To review the approach to treatment of HCC patients
  2. To review the studies and molecular mechanisms that drive the current standard of care
  3. To discuss current and future investigational therapeutics for HCC
Session date: 
09/11/2017 - 12:00pm to 1:00pm CDT
University of Chicago Medicine
5841 South Maryland Avenue
MC2115, Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel Olson, MD